张莎, 钟斌, 卜曦. 经皮冠状动脉介入治疗期间冠状动脉内输注阿替普酶对微循环功能的影响[J]. 实用临床医药杂志, 2022, 26(24): 66-70. DOI: 10.7619/jcmp.20221877
引用本文: 张莎, 钟斌, 卜曦. 经皮冠状动脉介入治疗期间冠状动脉内输注阿替普酶对微循环功能的影响[J]. 实用临床医药杂志, 2022, 26(24): 66-70. DOI: 10.7619/jcmp.20221877
ZHANG Sha, ZHONG Bin, BU Xi. Effects of intracoronary alteplase infusion on microcirculatory function during percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 66-70. DOI: 10.7619/jcmp.20221877
Citation: ZHANG Sha, ZHONG Bin, BU Xi. Effects of intracoronary alteplase infusion on microcirculatory function during percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 66-70. DOI: 10.7619/jcmp.20221877

经皮冠状动脉介入治疗期间冠状动脉内输注阿替普酶对微循环功能的影响

Effects of intracoronary alteplase infusion on microcirculatory function during percutaneous coronary intervention

  • 摘要:
    目的 探讨直接经皮冠状动脉介入治疗(PCI)期间冠状动脉内输注阿替普酶对微循环功能急性侵入性参数的影响。
    方法 选取心内科行急诊PCI的80例缺血时间≤6 h的急性ST段抬高型心肌梗死(STEMI)患者作为研究对象,采用随机数字表法分为阿替普酶组和对照组,每组40例。阿替普酶组于再灌注心肌梗死溶栓试验(TIMI)血流分级≥2级后将10 mg阿替普酶注入至冠状动脉罪犯血管中,然后植入支架;对照组于再灌注(TIMI血流分级≥2级)后立即植入支架。PCI后,检测2组微循环功能急性侵入性参数微循环阻力指数(IMR)、阻力储备比(RRR)和血流储备分数(CFR)。
    结果 阿替普酶组、对照组的IMR分别为22.0(17.0,42.0)、33.0(17.0,57.0),差异无统计学意义(P>0.05);阿替普酶组的CFR、RRR分别为1.4(1.1,1.9)、1.6(1.4,2.6),对照组的CFR、RRR分别为1.3(1.1,1.8)、1.6(1.3,2.2),差异无统计学意义(P>0.05)。亚组分析显示,缺血时间和阿替普酶与IMR无交互作用(P=0.155),缺血时间和阿替普酶与CFR(P=0.014)、RRR(P=0.027)存在交互作用。在缺血时间 < 2 h的患者中,阿替普酶组CFR、RRR依次为2.0(1.7,2.3)、2.2(2.0,2.6),分别高于对照组的1.2(1.1,1.7)、1.5(1.3,1.9),差异有统计学意义(P < 0.05)。
    结论 直接PCI期间向冠状动脉罪犯血管中输注阿替普酶,对缺血时间≤6 h的急性STEMI患者PCI结束时罪犯血管微循环功能(IMR、CFR、RRR)无明显影响。

     

    Abstract:
    Objective To investigate the effects of intracoronary alteplase infusion on acute invasive parameters on microcirculatory function during primary percutaneous coronary intervention (PCI).
    Methods A total of 80 acute ST-segment elevation myocardial infarction (STEMI) patients with ischemia time ≤ 6 h who underwent emergency PCI in the Department of Cardiology were included as study objects. The patients were divided into alteplase group and control group according to method of random number table, with 40 cases in each group. In the alteplase group, 10 mg of alteplase was infused into coronary criminal lesions after reperfusionblood flow grade of thrombolysis test for myocardial infarction (TIMI) ≥ 2, followed by stent implantation. The control group was implanted with stent immediately after reperfusion (blood grade of TIMI ≥ 2). Acute invasive parameters of microcirculatory functionmicrocirculatory resistance (IMR), resistance reserve ratio (RRR), and flow reserve (CFR) were measured after PCI.
    Results The IMR of the alteplase group and control group were 22.0(17.0, 42.0) and 33.0(17.0, 57.0), respectively, and there was no significant between-group difference (P>0.05). The CFR and RRR of the alteplase group were 1.4(1.1, 1.9) and 1.6(1.4, 2.6), respectively, and were 1.3(1.1, 1.8) and 1.6(1.3, 2.2), respectively in the control group, no significance between-group difference was observed (P>0.05). Subgroup analysis showed no interaction of ischemia time and alteplase with IMR(P=0.155). Interactions of ischemia time and alteplase with CFR (P=0.014) and RRR (P=0.027) were observed. In patients with ischemic times < 2 h, the CFR and RRR of the alteplase group were 2.0(1.7, 2.3) and 2.2(2.0, 2.6), respectively, which were higher than 1.2(1.1, 1.7) and 1.5(1.3, 1.9) of the control group (P < 0.05).
    Conclusion Infusion of alteplase to culprit artery microvascular has no significant effect on culprit artery microvascular function (IMR, CFR or RRR) during PCI in acute STEMI with ischemia time ≤ 6 h.

     

/

返回文章
返回